Critique of ICER’s Special Assessment to Inform CMS Drug Price Negotiation: Eliquis and Xarelto

That is the title of a new FTI Consulting white paper co-authored with Kyi-Sin Than. The abstract is below. In October 2023, ICER released a special assessment aimed at influencing CMS drug price negotiations for two direct-acting oral anticoagulants (DOACs) selected in the first round of Inflation Reduction Act (IRA) price negotiations in 2024: Eliquis®…

Read More

Medicaid and CHIP Eligibility, Enrollment, and Renewal Policies as States Resume Routine Operations Following the Unwinding of the Pandemic-Era Continuous Enrollment Provision

A KFF survey of state Medicaid officials examines state Medicaid and CHIP eligibility, enrollment, and renewal policies in place as of January 2025 as states return to routine operations following the unwinding of the continuous enrollment provision. The survey finds that states have broadly adopted policy and system changes to automate and improve the accuracy…

Read More

Fight Clinician Burnout with Better Interoperability Built on Clear Communication

Reversing this trend requires connecting disparate systems to enhance interoperability and communication and achieve more efficient, cohesive workflows. Implementing the infrastructure to streamline collaboration and reduce administrative burden will improve both staff well-being and patient outcomes. The post Fight Clinician Burnout with Better Interoperability Built on Clear Communication appeared first on MedCity News.

Read More